CDKN2A and hemoglobin measurement: Indeed, any pairwise or triple combination of B, Y and N overexpression is sufficient to promote HB initiation in mouse models of the disease, with concurrent Cdkn2a mutations being needed to derive immortalized cell lines from the primary tumors, as shown both here and elsewhere [6,12,15,47,48].